Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease (NCT04299945)
The Effects of Dietary Nitrate Supplementation on Exercise Tolerance in Patients With Fibrotic Interstitial Lung Disease
🩺 Plain-English Summary (8th-Grade Level)
Exercise training as part of a structured pulmonary rehabilitation program is a key factor in improving quality of life and symptoms in people with interstitial lung disease (ILD). Optimal methods of exercise training are yet to be explored in ILD. Drinking beetroot juice, which is rich in nitrate, has been shown to improve exercise performance in a variety of groups, but its effects in ILD have not been tested. The purpose of this study is to determine if drinking nitrate-rich beetroot juice can improve exercise performance compared to drinking nitrate-free beetroot juice in people with ILD.
Who can join: Review the eligibility criteria below.
Location: Providence Health Care - St. Paul's Hosptial — Vancouver, British Columbia
Age range: 19 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Providence Health Care - St. Paul's Hosptial — Vancouver, British Columbia
- Vancouver Coastal Health — Vancouver,
📞 Contact the Study Coordinator
Phone: (604) 806-8835
Email: Olivia.Ferguson@hli.ubc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Interstitial Lung Disease
- Genentech Validation Tool for Pulmonary Fibrosis — New York, New York
- FAPI PET for Lung Fibrosis — Los Angeles, California
- Interstitial Lung Disease Research Unit Biobank — Kansas City, Kansas
- Hyperpolarized 129Xe MRI for Imaging Pulmonary Function — Durham, North Carolina
- Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough — Rochester, Minnesota
- Pulmonary Hypertension SOLAR — Durham, North Carolina
Explore by condition: All Interstitial Lung Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.